Envista (NYSE:NVST) Given Neutral Rating at Piper Sandler

18 Sep 2026, 17:01 by Michael Walen · The Markets Daily

Envista (NYSE:NVST – Get Free Report)‘s stock had its “neutral” rating restated by research analysts at Piper Sandler in a note issued to investors on Friday, Benzinga reports. They presently have a $28.00 price target on the stock. Piper Sandler’s price objective points to a potential upside of 19.40% from the company’s previous close.

Other equities research analysts also recently issued research reports about the stock. Morgan Stanley set a $23.00 price target on shares of Envista in a research note on Thursday, August 6th. Robert W. Baird set a $34.00 price objective on shares of Envista in a report on Thursday, August 6th. Barclays decreased their price target on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday, June 11th. BMO Capital Markets reissued a “market perform” rating on shares of Envista in a report on Thursday, September 10th. Finally, UBS Group reduced their price target on shares of Envista from $30.00 to $27.00 and set a “neutral” rating on the stock in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, Envista presently has an average rating of “Moderate Buy” and an average price target of $29.86.

Check Out Our Latest Report on Envista

Envista Stock Performance

NVST traded down $0.24 on Friday, hitting $23.45. 1,224,427 shares of the stock traded hands, compared to its average volume of 2,896,582. Envista has a 52 week low of $18.77 and a 52 week high of $30.42. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $3.77 billion, a PE ratio of 40.40, a P/E/G ratio of 1.19 and a beta of 0.86. The business has a fifty day moving average price of $27.01 and a two-hundred day moving average price of $26.06.

Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company had revenue of $730.50 million during the quarter, compared to the consensus estimate of $716.11 million. During the same quarter last year, the company earned $0.26 EPS. The company’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, research analysts predict that Envista will post 1.53 EPS for the current fiscal year.

Insider Activity at Envista

In other news, SVP Mischa Reis sold 8,000 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the sale, the senior vice president directly owned 27,321 shares in the company, valued at approximately $751,327.50. This trade represents a 22.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.99% of the company’s stock.

Institutional Investors Weigh In On Envista

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NVST. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Envista in the second quarter valued at approximately $25,000. Allworth Financial LP lifted its holdings in Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after buying an additional 776 shares in the last quarter. IFP Advisors Inc lifted its holdings in Envista by 102.9% during the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after buying an additional 1,071 shares in the last quarter. Nykredit A S bought a new position in Envista in the 2nd quarter valued at $52,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in shares of Envista in the 2nd quarter valued at $63,000.

Key Headlines Impacting Envista

Here are the key news stories impacting Envista this week:

Positive Sentiment: Envista is described as technically oversold after the recent selloff, suggesting that heavy selling pressure may be weakening. Zacks also cited broad upward revisions to earnings estimates, which could support a near-term rebound. Down 12% in 4 Weeks, Here’s Why You Should Buy the Dip in Envista
Positive Sentiment: Zacks highlighted Envista as a potential value opportunity, which may attract investors following the stock’s recent decline. However, the article is based primarily on valuation and factor signals rather than a new company announcement. Should Value Investors Buy Envista Stock?
Neutral Sentiment: Envista’s analyst and investor day materials were published, giving investors additional information on management’s strategy and outlook. The available reports do not identify a major new catalyst or guidance change. Envista Analyst/Investor Day Transcript
Neutral Sentiment: Needham reaffirmed its “hold” rating, indicating that the firm does not see enough near-term upside or downside to change its view. Needham rating report
Negative Sentiment: UBS lowered its price target to $27 from $30 while maintaining a “neutral” rating. Although the revised target remains above the recent market level, the reduction signals more limited expected upside and likely contributed to investor caution. UBS Adjusts Envista Price Target

Envista Company Profile

(Get Free Report)

Envista Holdings Corporation is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral-care professionals.